MedTrace Logo

Daxor - Blood Volume Analysis

NCT04111185 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2023-06-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to better understand blood volume status and whether knowledge of it can change and improve heart failure care.

Conditions

Interventions

DEVICE

Receive Blood Volume Analysis Guided Treatment

The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis

Sponsors & Collaborators

Principal Investigators

  • G. Michael Felker, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-16
Primary Completion
2021-07-15
Completion
2021-09-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111185 on ClinicalTrials.gov